Home/Filings/4/0001213900-21-051646
4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-21-051646

CIK 0001513525other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 5:22 PM ET

Size

7.8 KB

Accession

0001213900-21-051646

Insider Transaction Report

Form 4
Period: 2021-10-04
Johnson Bankole A.
Director10% Owner
Transactions
  • Other

    Warrant

    2021-10-04150,00039,714 total
    Common Stock (150,000 underlying)
  • Sale

    Common Stock

    2021-10-04200,000148,246 total(indirect: By Trust)
Footnotes (3)
  • [F1]En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000.
  • [F2]Dr. Johnson is the trustee of the Trust.
  • [F3]On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1
  • filerCIK 0001718158

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:22 PM ET
Size
7.8 KB